Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Subintimal vs. Intraplaque Coronary Rechanneling. Do Results Vary?

Coronary rechanneling is difficult by nature, and there are several techniques for it aimed at improving technical success. Some of these strategies entail the subintimal crossing of the occluded segment, while others entail intraplaque crossing, without leaving the true lumen. However, there is scarce or no information on the results of both strategies.

Researchers analyzed 75 consecutive patients undergoing angiography and optical coherence tomography (OCT) after rechanneling, who were included in the ISAR-OCT-CTO (Intracoronary Stenting and Angiographic Results – Optical Coherence Tomography for Chronic Total Occlusions) registry. The study endpoints were stenosis diameter, lumen loss, and rate of uncovered or malapposed struts.

Intraplaque rechanneling was used in 46 patients, while dissection and re-entry techniques were used in 29 patients.


Read also: Prosthesis Mismatch in Supra and Intra Annular valves.


There were no significant differences in terms of in-segment stenosis diameter (mean 36.9% vs. 31.2%; p = 0.656), in-stent late lumen loss (0.21 mm vs. 0.23 mm; p = 0.83), or in-segment late lumen loss (0.03 vs. 0.13; p = 0.39) between intraplaque vs. subintimal techniques.

The OCT imaging analysis showed comparable strut coverage (79.9% vs. 71.3%; p = 0.255) but much higher malapposition rates among patients in the subintimal technique group (6.6% vs. 13.6%; p < 0.001).

The use of dissection and re-entry techniques only predicted higher rates of strut malapposition.

Conclusion

Intraplaque and subintimal rechanneling techniques are associated with comparable mid-term angiographic results. Although the rate of uncovered struts is high after any rechanneling, it does not vary according to the technique used.

The only difference observed is a higher chance of strut malapposition with dissection and re-entry techniques.

Original title: Subintimal Versus Intraplaque Recanalization of Coronary Chronic Total Occlusions. Mid-Term Angiographic and OCT Findings From the ISAR-OCT-CTO Registry.

Reference: Erion Xhepa et al. J Am Coll Cardiol Intv 2019, Article in press.



Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...